Table 2.
AST, ALT, and LDH activities and TC, LDL-C, and HDL-C in plasma levels in control, HFFD, and HFFD rats treated with MSM.
| Control (0 day) | Control (90 days) | HFFD | HFFD + MSM | |
|---|---|---|---|---|
| AST | 30.7 ± 3.5 | 36.1 ± 4.6 | 76.1 ± 9.6∗# | 47.7 ± 7.44∗#@ |
| ALT | 35.3 ± 7 | 41.3 ± 3.7 | 64.3 ± 5.9∗# | 52.1 ± 9.1∗#@ |
| LDH | 19.5 ± 1.9 | 21 ± 2.1 | 31 ± 1.9∗# | 27.9 ± 4.2∗#@ |
| TC (g/l) | 1.21 ± 0.12 | 1.34 ± 0.12 | 1.68 ± 0.12∗# | 1.39 ± 0.11∗@ |
| LDL-C (g/l) | 0.56 ± 0.07 | 0.65 ± 0.08 | 1.29 ± 0.05∗# | 0.66 ± 0.09∗@ |
| HDL-C (g/l) | 0.65 ± 0.08∗ | 0.69 ± 0.06 | 0.39 ± 0.06∗# | 0.73 ± 0.05#@ |
∗ P < 0.05 significant differences compared to controls (0 day). #P < 0.05 significant differences compared to controls (90 days). @P < 0.05 significant differences compared to HFFD rats.